Sun Pharmaceutical Industries’ subsidiary Caraco has reportedly received US Food and Drug Administration (US FDA) approval for Risperidone oral tablets. The oral tablet is used for the treatment of schizophrenia (a mental disorder).
Recently, the healthcare major had voluntarily recalled 2,528 bottles of its generic version of diabetes drug Glumetza from US-based Santarus Inc after it received a customer complaint.
Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.
